Invo BioScience Inc. (INVO) Reports Q3 Loss, Lags Revenue Estimates

Invo BioScience Inc. (INVO) delivered earnings and revenue surprises of -20.00% and -13.10%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for…

Leave a comment

Your email address will not be published. Required fields are marked *